Altai Protocol Library
1041 protocols and counting
All protocols with references and links
All protocols reviewed by a Medical Oncologist/Hematologist
All protocols in major guidelines included
Ability to create your own protocols
New Indication: Atezolizumab in advanced alveolar soft part sarcoma (ASPS)
Study: Open-label, multicenter, phase 2 study Unresectable or metasatic ASPS Atezolizumab 1200 mg in adults (n=47) or 15 mg/kg (1200 mg max) in pediatric pts (n=2) once q21 days. Efficacy:
New Indication: Atezolizumab for early-stage NSCLC
Study: Open-label Phase III trial (IMpower010) Completely resected early-stage NSCLC s/p adjuvant platinum-based chemo Atezolizumab 1200 q21 x 1 yr vs. best supportive care Efficacy: Among pts with stage II-IIIA